Same-day shipping on USA orders placed before 2PM EST.
View Shipping Policy →
Selank 5mg
SKU: SELNK-5M10

30-day hassle-free returns on unopened products.
View Returns Policy →Every batch is tested for purity, potency and quality.
View Lab Results →Have a question? Our team is here to help you.
Contact Us →Selank (TKPRPGP) is a synthetic heptapeptide analogue of the immunomodulatory tetrapeptide tuftsin (Thr-Lys-Pro-Arg), with a C-terminal Pro-Gly-Pro extension that confers resistance to peptidase degradation. Experimental investigations have examined peptide-mediated signaling pathways, GABAergic-associated regulatory systems, receptor-ligand interactions, and transcriptional control mechanisms. Research applications include tuftsin-associated pharmacology, peptide-signaling pathway investigation, GABAergic signaling studies, signal transduction research, and mechanistic evaluation of peptide-mediated regulatory networks.
- High Purity — 99%+ Purity Guaranteed
- Independently Lab Tested
- Research Grade Quality
- For Laboratory Research Use Only
| Chemical Formula | C33H57N11O9 |
|---|---|
| Synonyms | Thr-Lys-Pro-Arg-Pro-Gly-Pro, L-Proline, L-threonyl-L-lysyl-L-prolyl-L-arginyl-L-prolylglycyl-, Selanc, UNII-TS9JR8EP1G |
| Molar Mass | 751.89 g/mol |
| CAS Number | 129954-34-3 |
| PubChem CID | 11765600 |
| Total Compound Content | 5 mg per vial |
| Shelf Life | 36 months |
No lab reports have been added yet.
How is Selank structurally related to tuftsin and what does the C-terminal extension contribute?
Selank is derived from the tetrapeptide tuftsin (Thr-Lys-Pro-Arg), incorporating a Pro-Gly-Pro extension at the C-terminus to form the heptapeptide TKPRPGP. This structural modification influences peptide stability characteristics and resistance to enzymatic degradation relative to the parent peptide. The extension also alters the physicochemical and pharmacological properties of the molecule, making Selank a useful research tool for studies of peptide engineering, structure-function relationships, and peptide-mediated signaling systems.
How does Selank differ from classical small-molecule modulators in peptide pharmacology research?
Selank is a synthetic peptide with a distinct structural and pharmacological profile compared to classical small-molecule compounds. Experimental investigations have examined its interactions with peptide-mediated signaling pathways, GABAergic-associated regulatory systems, receptor-ligand interactions, and molecular communication networks. These characteristics make Selank valuable for studies investigating peptide-based signaling mechanisms, signal transduction processes, and receptor-associated regulatory pathways.
What regulatory properties have been investigated for Selank in experimental research?
Consistent with its tuftsin-derived sequence, Selank has been investigated in relation to peptide-associated regulatory pathways, molecular signaling networks, and receptor-mediated communication systems. Experimental studies have examined interactions with transcriptional control mechanisms, signaling cascades, and peptide-dependent regulatory processes. These properties have established Selank as a useful research tool for investigations of peptide pharmacology, signal transduction, molecular regulation, and mechanistic evaluation of peptide-mediated biological systems.